ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,154Medicare Part D Prescriptions Filled, Including Refills

Rank: 219 out of 3593

$1.14M Total Retail Price of All Prescriptions

Rank: 98 out of 3593

694 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 694 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 13,808 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
CRESTOR 551 455 1 21
OMEPRAZOLE 483 416 2 5
NEXIUM 458 382 3 36
SIMVASTATIN 443 374 4 1
METFORMIN HCL 410 343 5 6
LISINOPRIL 331 290 6 2
AMLODIPINE BESYLATE 325 305 7 3
ZOLPIDEM TARTRATE 301 260 8 12
ATORVASTATIN CALCIUM 273 244 9 15
GABAPENTIN 269 226 10 16
DIOVAN 259 246 11 46
METOPROLOL SUCCINATE 242 231 12 19
ATENOLOL 228 228 13 11
LIDODERM 224 147 14 78
CLOPIDOGREL 213 195 15 30
METOPROLOL TARTRATE 208 163 16 8
PLAVIX 205 171 17 42
LEVOTHYROXINE SODIUM 196 147 18 4
VOLTAREN 194 147 19 85
RANITIDINE HCL 177 150 20 27
IBUPROFEN 171 146 21 43
LOVAZA 165 143 22 106
WARFARIN SODIUM 163 158 23 18
DONEPEZIL HCL 141 134 24 31
CARVEDILOL 140 140 25 23
NASONEX 140 116 25 192
GLIMEPIRIDE 139 110 27 44
DIGOXIN 138 138 28 58
FAMOTIDINE 129 123 29 70
ADVAIR DISKUS 129 79 29 47
LOSARTAN POTASSIUM 127 124 31 14
FUROSEMIDE 126 123 32 9
CITALOPRAM HBR 126 122 32 25
FLUTICASONE PROPIONATE 121 90 34 32
DICLOFENAC SODIUM 115 85 35 74
SINGULAIR 115 78 35 77
PANTOPRAZOLE SODIUM 113 109 37 45
NAMENDA 112 112 38 50
CLONIDINE HCL 112 102 38 41
HYDROCHLOROTHIAZIDE 111 78 40 10
TRIAMCINOLONE ACETONIDE 104 92 41 119
JANUVIA 99 85 42 81
ALENDRONATE SODIUM 98 98 43 22
AZITHROMYCIN 96 78 44 34
TEMAZEPAM 94 93 45 56
TAMSULOSIN HCL 94 82 45 33
LANSOPRAZOLE 89 81 47 113
LANTUS 88 75 48 57
ESCITALOPRAM OXALATE 85 82 49 71
TRICOR 83 49 50 130
MUPIROCIN 82 73 51 132
DEXILANT 81 47 52 222
PROAIR HFA 79 57 53 54
INSULIN SYRINGE 79 77 53 91
ENALAPRIL MALEATE 78 69 55 38
DIOVAN HCT 78 77 55 76
BENICAR HCT 77 72 57 155
CLOTRIMAZOLE-BETAMETHASONE 76 52 58 94
EXELON 74 54 59 123
MECLIZINE HCL 71 64 60 96
FENOFIBRATE 70 70 61 39
BUMETANIDE 70 70 61 148
GLIPIZIDE 70 70 61 40
LOVASTATIN 69 58 64 20
ISOSORBIDE MONONITRATE ER 68 60 65 61
DOXAZOSIN MESYLATE 67 63 66 63
CELEBREX 67 59 66 100
KETOCONAZOLE 65 53 68 118
POTASSIUM CHLORIDE 65 65 68 24
GLYBURIDE-METFORMIN HCL 65 59 R 68 95
SURE COMFORT 64 54 71 159
LACTULOSE 64 48 71 126
BYSTOLIC 63 52 73 182
TRAMADOL HCL 62 39 74 17
SERTRALINE HCL 62 28 74 28
ALLOPURINOL 62 62 74 35
MONTELUKAST SODIUM 61 44 77 151
DICYCLOMINE HCL 60 41 78 190
ACTOS 59 37 79 133
VESICARE 59 54 79 205
LOSARTAN-HYDROCHLOROTHIAZIDE 56 36 81 48
TRAZODONE HCL 54 44 82 53
MELOXICAM 53 48 83 29
NITROSTAT 51 47 84 224
NATEGLINIDE 51 40 84 345
NOVOLIN 70-30 50 50 86 146
NAPROXEN 50 41 86 68
AMLODIPINE BESYLATE-BENAZEPRIL 50 47 86 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.